Key Highlights

  • BBAI shares advanced 10.9% during Tuesday’s session, followed by a 1.7% gain in pre-market trading Wednesday
  • Volume reached approximately 68 million shares, representing a 36% increase over typical daily activity
  • First quarter 2026 financial results scheduled for release on May 5; Wall Street projects EPS of -$0.08 and revenue near $33.6M
  • HC Wainwright maintains the Street’s most optimistic price target at $6, representing potential upside of approximately 45%
  • Consensus analyst targets ranging from $5.33 to $5.50 indicate roughly 30% appreciation from present levels

BigBear.ai shares delivered a robust performance on Tuesday, advancing 10.9% to settle near $4.14. The session featured elevated trading activity, with approximately 68 million shares changing hands — significantly exceeding the typical range of 37 to 50 million.


BBAI Stock Card
BigBear.ai Holdings, Inc., BBAI

Wednesday’s pre-market session extended the gains with an additional 1.7% increase, maintaining positive momentum as the week progresses.

The upward movement appears driven by accumulation rather than specific catalyst announcements. Market participants seem to be positioning in AI-enabled defense analytics stocks ahead of the approaching earnings cycle.

BBAI plans to announce Q1 2026 financial performance on May 5. The Street consensus calls for a per-share loss of $0.08, which would represent substantial improvement compared to the $0.25 deficit recorded during Q1 2025.

Topline expectations point to revenue of $33.6 million — representing a year-over-year decline exceeding 3%. The company’s latest quarterly disclosure revealed revenue of only $27.3 million, marking a 37.7% decrease versus the comparable prior-year period.

The previous quarter delivered a modest bottom-line surprise. BBAI recorded -$0.01 EPS against analyst expectations of -$0.05, although revenue fell short of projections.

Critical Factors for the Quarter

Market participants will focus intently on contract announcements and federal spending trends when Q1 figures emerge.

BBAI’s topline performance depends heavily on U.S. defense and government contracts. Securing new agreements and converting pipeline opportunities will serve as crucial indicators of business momentum.

The Ask Sage GenAI platform represents another area of interest. BBAI completed the $250 million acquisition of this technology. HC Wainwright analyst Scott Buck views the transaction as potentially accelerating growth while enhancing profitability metrics, positioning it as a significant contributor to 2026 performance.

Buck maintains the Street’s highest valuation at $6 — approximately 45% above current trading prices. He highlighted the company’s balance sheet strength as providing runway for additional strategic transactions.

Analyst coverage of BBAI remains limited. Current Street sentiment includes three ratings: one Buy, one Hold, and one Sell across different research platforms. Consensus price objectives range between $5.33 and $5.50.

Cantor Fitzgerald reduced its target from $6 to $5 during March while assigning a neutral stance. HC Wainwright lowered its objective from $8 to $6 while maintaining a buy recommendation. Weiss Ratings has issued a sell rating on the equity.

Regarding institutional ownership, multiple significant asset managers expanded positions during Q4. Vanguard increased its stake by 18.4%, UBS roughly doubled its holdings, and State Street boosted exposure by 33.6%.

Insider activity included one March transaction. Director Pamela Joyce Braden divested 80,000 shares at $4.00 per unit, decreasing her ownership position by roughly 13.6%.

The company maintains a market capitalization near $1.98 billion, exhibits a beta of 3.47, and carries a debt-to-equity ratio of 0.16. The 50-day moving average stands at $3.75, while the 200-day average sits at $5.25.

The upcoming earnings announcement on May 5 will provide definitive quarterly metrics for investor assessment.